SPARC announces retirement of Dr Chitturi Trinadha Rao - Senior Vice President, Drug Discovery
Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced that Dr Chitturi Trinadha Rao – Senior Vice President, Drug Discovery, has retired from the Company.
"We would like to inform about that Dr Chitturi Trinadha Rao – Senior Vice President, Drug Discovery, retired from the Company with effect from closing of business hours of October 31, 2023," the Company informed in a BSE filing.
Dr Rao carries over 22 years of experience in synthetic organic/ medicinal chemistry together at SPIL & SPARC Ltd. Prior to joining SUN, Dr Rao was associated with GlaxoSmithkline Pharmaceuticals Ltd. Thane, as Group Leader in Chemistry R&D. for about 4 years.
Read also: SPARC concludes enrolment in global Phase 2 study of Vodobatinib in early Parkinson's disease
SPARC is a clinical stage bio-pharmaceutical company. SPARC was formed in 2007 through a demerger from SUN PHARMA.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.